文献速递胸部肿瘤放疗放疗物理与技术

NRG放射治疗试验应采用何种剂量规范:介质剂量还是水剂量?

Which Dose Specification Should Be Used for NRG Radiation Therapy Trials: Dose-to-Medium or Dose-to-Water?
PubMed 文献 · Pract Radiat Oncol · 2019-08-31

结果显示AAA与Acuros Dm,m的CTV D100差异最大达14.12%,平均差异5.39%,远大于AAA与Acuros Dw,m的差异(最大3.68%)。提示需进一步明确NRG临床试验应采用的剂量报告模式。

要点

  • AAA与Acuros Dm,m的CTV D100差异最大14.12%,平均5.39%。
  • AAA与Acuros Dw,m的CTV D100差异最大仅3.68%。
  • Acuros Dm,m与AAA的CTV覆盖率平均91.32%,低于Dw,m的98.94%。

核心结论

  • AAA与Acuros Dm,m计算的剂量存在大而系统的差异,需进一步研究和明确NRG临床试验应采用的剂量报告模式。

研究设计与样本

  • 所有计划使用与原批准计划相同的机器跳数和2.5 mm网格尺寸。
  • 比较每位患者CTV的D100及覆盖率,并比较剂量分布和剂量体积直方图。

主要发现

  • AAA与Acuros Dm,m的CTV D100差异大于AAA与Acuros Dw,m的差异(所有患者)。
  • AAA与Acuros Dm,m的CTV D100最大差异14.12%,平均差异5.39%。
  • AAA与Acuros Dw,m的CTV D100最大差异3.68%。
  • Acuros Dm,m与AAA的覆盖率范围51.08%–100%,平均91.32%;Acuros Dw,m与AAA的覆盖率范围87.2%–100.41%,平均98.94%。
  • Acuros Dm,m与Acuros Dw,m的覆盖率范围58.58%–100%,平均92.03%。

临床怎么用

  • 在肺癌IMRT/VMAT计划中,若使用Acuros介质剂量模式报告,需注意其与AAA的CTV D100和覆盖率存在显著差异。
  • 参与NRG临床试验时,应关注并明确所采用的剂量报告模式(介质剂量或水剂量)。

局限性

  • 为回顾性分析,所有计划使用相同机器跳数和2.5 mm网格尺寸。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the doses calculated by the Analytical Anisotropic Algorithm (AAA), Acuros dose-to-medium, and Acuros dose-to-water for the patients with lung cancer treated at our institution and show that further investigation and clarification are needed about what dose specifications should be used for NRG clinical trials. METHODS AND MATERIALS: Twenty-one patients with lung cancer who previously received intensity modulated radiation therapy or volumetric modulated arc therapy-based treatments at our institution were analyzed by recalculating their plans for each one with the AAA algorithm (reviewed and approved by our radiation oncologists) and with both reporting modes of the Acuros algorithm. All plans used the same monitor units as the original approved plan and a 2.5-mm grid size. For each patient, D100 of clinical target volume (CTV) and CTV coverage ratios in each plan were compared, and dose distributions and dose-volume histograms calculated by AAA, Acuros dose-to-water (Dw,m), and Acuros dose-to-medium (Dm,m) were compared as well. RESULTS: Differences between CTV D100 calculated by AAA and Acuros Dm,m were larger than the differences between AAA and Acuros XB Dw,m for all patients. When D100 of CTV was evaluated, the largest difference between AAA and Acuros Dm,m was 14.12% and between AAA and Acuros XB Dw,m was 3.68%. The average differences between the CTV D100 calculated by AAA and Acuros Dm,m was 5.39%. Coverage ratio between Acuros Dm,m and AAA ranges from 51.08% to 100% with an average of 91.32%; coverage ratio between Acuros Dw,m and AAA ranges from 87.2% to 100.41% with average of 98.94%; coverage ratio between Acuros Dm,m and Acuros Dw,m ranges from 58.58% to 100% with an average of 92.03%. CONCLUSIONS: The present study shows large and systematic differences in doses calculated by AAA and Acuros Dm,m. Therefore, further investigation and clarification are needed about which dose reporting mode should be used.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Cabanas ML, Yan C, Lalonde RJ, et al. Which Dose Specification Should Be Used for NRG Radiation Therapy Trials: Dose-to-Medium or Dose-to-Water? Pract Radiat Oncol. 2019. PMID: 31479770. doi:10.1016/j.prro.2019.08.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。